Suven Pharmaceuticals Ltd. Fundamental & Technical Research, Share Price Today

NSE : SUVENPHAR
NIFTY : Nifty 500
NIFTY SECTOR : Nifty MidSmall Healthcare

About Company

Suven Pharmaceuticals Limited is a bio-pharmaceutical company, incorporated with the object of being engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies. Suven Pharma Inc., a Delaware Company, is a WOS (wholly owned subsidiary) of SPL, is a SPV (Special Purpose Vehicle) created on 9th March 2019, for undertaking various business opportunities in Pharma Industry.

Market Cap. ₹28,929 Cr.

52 Week - High/Low ₹1,360/598

P/E Ratio 102.84

P/B Ratio 14.07

Enterprise Value ₹28,987 Cr.

ROE % 16.03

RSI Value 53.04

EMA 50 1147.4

EMA 200 1080.29

Market Cap. ₹28,929 Cr.

52 Week - High/Low ₹1,360/598

P/E Ratio 103.50

P/B Ratio 14.11

Enterprise Value ₹28,975 Cr.

ROE % 15.87

RSI Value 53.04

EMA 50 1147.4

EMA 200 1080.29

Add Parameters

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Terms | Privacy | Contact Us